Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults
Open Access
- 4 November 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (11) , e2443551
Abstract
Meningococcal infection, caused by the bacterium Neisseria meningitidis, is associated with severe disease, most commonly meningitis or sepsis. Long-term sequelae include limb loss, skin scarring, seizures, and neurologic impairment, such as hearing and vision loss, among other disabilities.1,2 Colonization with N meningitidis is common, particularly among older adolescents,3 and is a substantial source of transmission to others. Twelve serogroups of N meningitidis have been identified, but most cases of invasive meningococcal disease (IMD) are caused by serogroups A, B, C, W, X, and Y worldwide.4 The burden of IMD varies by country and region, ranging from less than 1 case per 100 000 population in some industrialized countries5 to more than 100 cases during outbreaks in the meningitis belt of sub-Saharan Africa.6 Although not typically a seasonal disease,7 most cases tend to occur during the winter and early spring months.8Keywords
This publication has 24 references indexed in Scilit:
- Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in GermanyInfectious Diseases and Therapy, 2024
- Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programmeClinical Microbiology and Infection, 2022
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluationsHealth Policy OPEN, 2022
- Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance StudyClinical Infectious Diseases, 2021
- The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccinationJournal of Infection, 2020
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United StatesJAMA Pediatrics, 2020
- Epidemiology of Meningococcal Disease Outbreaks in the United States, 2009–2013Clinical Infectious Diseases, 2018
- Meningococcal disease: Clinical presentation and sequelaeVaccine, 2012
- Meningococcal carriage by age: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996The Journal of Infectious Diseases, 1999